Táblázat minta scroll

In vivo kit DMSA 1.5 mg DTPA 9 mg EC 2 mg
Product Code Tc-IK-7 Tc-IK-8 Tc-IK-25
ATC code V09CA02 V09CA01 V09CA
Marketing Authorisation No. OGYI-T9245/01 OGYI-T-9244/01 OGYI-T-9141/01
For preparation of Technetium (99mTc) succimer injection Technetium (99mTc) pentate injection Technetium (99mTc) EC injection
Active ingredient Dimercaptosuccinic acid Diethylenetriamino pentaacetic acid Ethylene-dicysteine
Content/vial 1.5 mg 9.0 mg 2.0 mg
Excipients
  • Stannous chloride dihydrate
  • Ascorbic acid
  • Calcium gluconate
  • Stannous chloride dihydrate
  • Ascorbic acid
  • Sodium chloride
 Vial A

  • Disodium hydrogen phosphate dihydrate
  • Mannitol
  • Ascorbic acid
  • Sodium edetate

Vial B

  • Stannous chloride dihydrate
  • Ascorbic acid
  • Tartaric acid

Vial C

  • Potassium dihydrogen phosphate
  • Ascorbic acid
Indications
  • Kidney scintigraphy, static kidney imaging, localisation of the
    kidneys with imaging
  • Determination of the functional mass of the kidney
  • Determination of the relative function ratio (percentage) of the
    left and right kidneys
  • Dynamic studies of kidney, determination of kidney perfusion,
    glomerural filtration rate, total and partial kidney function
  • Examination of the cerebral blood circulation
  • Examination of the gastrointestinal tract by using labelled
    foodstuff or drink
  • Examination of liquor circulation
  • Dynamic studies of kidney for renal tubular function
Activity for labelling vial 1.0–1.8 GBq 0.8–2.4 GBq 0.8–1.6 GBq
Vials per kit 6 injection vials 6 injection vials 3 x 4 injection vials
Recommended doses See in the Summary of Product Charasteristics See in the Summary of Product Charasteristics See in the Summary of Product Charasteristics
Shelf life 24 months
after radiolabelling: 8 h		 12 months
after radiolabelling: 8 h		 12 months
after radiolabelling: 8 h
Storage 2-8°C
after radiolabelling: ≤ 25°C		  ≤ 25°C
after radiolabelling: ≤ 25°C 		2-8°C
after radiolabelling: ≤ 25°C
SPC